Current guidelines for patients with suspected acute myocardial infraction are mainly based on troponin testing, commonly requiring an emergency department visit. HEAR score (History, electrocardiogram, Age and Risk factors) is a risk stratification tool validated in Europe, deduced from the HEART score, already implemented in clinical practice. We aimed to validate the HEAR score to rule-out an acute myocardial infraction without needing biomarker testing.